Myriad Genetics | MYGN - Market Capitalization

Stock Price
3.58
Daily Change
-0.04 -1.11%
Monthly
-28.40%
Yearly
-13.32%
Q2 Forecast
3.51

Myriad Genetics reported $325.3M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 37.86B 3.64B Dec/2025
Becton, Dickinson and Co. USD 44.45B 323M May/2026
Bruker USD 6.41B 915M May/2026
Danaher USD 128.46B 33.24B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Mettler Toledo International USD 28.34B 2.8B May/2026
Myriad Genetics USD 575M 98M Dec/2025
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Quidel USD 780M 226M May/2026
Repligen USD 7.01B 360M May/2026
Revvity USD 11.4B 1.46B May/2026
Standard Biotools USD 492M 5M Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Veracyte USD 2.59B 16M May/2026
Waters USD 21.02B 8.84B May/2026